← Eichor
Study identifier: NCT07428876 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The Effects of SITS in Children With Autism.

Condition: Child, Only  ·  Sponsor: Riphah International University

PhaseNA
Planned participants26
Who can joinAll sexes, 5 Years to 11 Years
Healthy volunteersNo

About this study

The study will include 30 participants whose pre and post values will be calculated. Inclusion criteria for this study is autism spectrum disorder with the age group of 5\_11 years ,female and males both are included, those who are physically handi-capped and involved in some other neurological disorder or taking hypnotic and sedative drugs will be excluded. Participants will receive sensory integrated exercises (SIT) . Outcome to be measure and analyze will be repetitive behavior, communication, social interaction and motor skills. Tools used for data collection are REPETITIVE BEHAVIOUR QUESTIONNAIRE (RBQ-2). Gallium autism rating scale (GARS) second edition. Data will be analyzed through the SPSS version 23:00

This description comes directly from the study's public registry record.

Talk to the study team

IMRAN AMJAD, Phd  ·  9233224390125  ·  imran.amjad@riphah.edu.pk

Muhammad Asif Javed, MS-PT  ·  923224209422  ·  a.javed@riphah.edu.pk

Always discuss trial participation with your own doctor first.

Locations (1)

Saeeda MaryumLahore, Punjab Province, PakistanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07428876